Table 3 Patient-visit clinical diagnoses or medication use which are relative contraindications for opioids
|  | No opioid prescription at office visit n = 23,541 | Opioid prescription at office visit n = 1002 | Total sample n = 24,543 | P-Value |
|---|---|---|---|---|
N (%) | N (%) | N (%) | ||
Depression Disorder | ||||
 No | 21,206 (96.0) | 876 (4.0) | 22,082 |  |
 Yes | 2335 (9.9) | 126 (12.6) | 2461 | < 0.01 |
Anxiety Disorder | ||||
 No | 20,333 (96.1) | 830 (3.9) | 21,163 |  |
 Yes | 3208 (94.9) | 172 (5.1) | 3380 | < 0.01 |
Substance Use Disorder | ||||
 No | 22,168 (96.2) | 875 (3.8) | 23,043 |  |
 Yes | 1373 (91.5) | 127 (8.5) | 1500 | < 0.001 |
Bipolar Disorder | ||||
 No | 23,275 (96.0) | 975 (4.0) | 24,250 |  |
 es | 266 (90.8) | 27 (9.2) | 293 | < 0.001 |
Benzodiazepine Prescribed at Index Visit | Â | |||
 No | 22,989 (96.1) | 925 (3.9) | 23,914 |  |
 es | 552 (87.8) | 77 (12.2) | 629 | < 0.001 |